Pegylated interferons for chronic hepatitis C virus infection
Interferon and ribavirin therapy does not select for resistance mutations in hepatitis C virus polymerase
Refined analysis of genetic variability parameters in hepatitis C virus and the ability to predict antiviral treatment response
Viral kinetic of HCV genotype-4 during pegylated interferon alpha 2a
Antiviral therapy of hepatitis C in chronic kidney diseases
Bone marrow-derived mesenchymal stem cells are capable of mediating hepatitis B virus infection in injured tissues
High prevalence of significant histology in asymptomatic chronic hepatitis B patients with genotype C and high serum HBV DNA levels
Hepatitis RNA viruses and hepatocellular carcinoma